Abstract:Heart failure (HF) is a sophisticated syndrome with structural or functional impairment of ventricular filling or ejection of blood, either causing symptoms and signs or being asymptomatic. HF is a major global health issue affecting about 64.3 million people worldwide. The gut microbiota refers to the complex ecosystem of microorganisms, mainly bacteria, in the gut. Studies have revealed that the gut microbiota is associated with many diseases ranging from neurodegenerative diseases to inflammatory bowel disease and cardiovascular diseases. The gut hypothesis of HF suggests that low cardiac output and systemic circulation congestion would cause insufficient intestinal perfusion, leading to ischemia and intestinal barrier dysfunction. The resulting bacterial translocation would contribute to inflammation. Recent studies have refined the hypothesis that changes of metabolites in the gut microbiota have a close relationship with HF. Thus, the gut microbiota has emerged as a potential therapeutic target for HF due to both its critical role in regulating host physiology and metabolism and its pivotal role in the development of HF. This review article aims to provide an overview of the current understanding of the gut microbiota's involvement in HF, including the introduction of the gut hypothesis of HF, its association with HF progression, the potential mechanisms involved mediated by the gut microbiota metabolites, and the impact of various interventions on the gut microbiota, including dietary interventions, probiotic therapy, fecal microbiota transplantation, antibiotics, and so on. While the gut hypothesis of HF is refined with up-to-date knowledge and the gut microbiota presents a promising target for HF therapy, further research is still needed to further understand the underlying mechanisms between gut microbiota and HF, the efficacy of these interventions, and contribute to the health of HF patients.

Gut microbiota in cardiovascular disease and heart failure

Dietary metabolism, the gut microbiome, and heart failure

Gut microbiota and microbiota-derived metabolites in cardiovascular diseases

Exploring the Microbiome in Heart Failure

Gut microbiota: Implications in pathogenesis and therapy to cardiovascular disease (Review)

Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review

Update on gut microbiota in cardiovascular diseases

The Role of the Gut Microbiota in Health and Cardiovascular Diseases

Gut microbiota in heart failure and related interventions

Gut Microbiota and Heart, Vascular Injury.

Human microbiome and cardiovascular diseases

The Emerging Role of Gut Dysbiosis in Cardio-metabolic Risk Factors for Heart Failure

The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions

Gut macrobiotic and its metabolic pathways modulate cardiovascular disease

Recent advances on the Role of Gut Microbiota in the Development of Heart Failure by Mediating Immune Metabolism

The Gut Microbiota and Its Interactions with Cardiovascular Disease

The role of intestinal microbiota in cardiovascular disease

Current Understanding of Gut Microbiota Alterations and Related Therapeutic Intervention Strategies in Heart Failure

Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure

Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship

[Gut microbiota and cardiovascular disease-insights into the potential and challenges of drug discovery]